How are Monoclonal Antibodies Used in Neonatal Disorders?
In the context of neonatal disorders, mAbs are employed primarily for the prevention and treatment of infectious diseases. Newborns, especially preterm infants, have underdeveloped immune systems, making them susceptible to infections. One of the most notable applications is in the prevention of Respiratory Syncytial Virus (RSV) infections, a significant cause of respiratory illness in infants.
